Chester Rogers
Family Medicine · Bourbon, INNPI 1689613382
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $678 and has fallen 97.7% since, to $16 in 2024.
Across 118 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$311
- Pfizer$231
- Amgen$227
- Johnson & Johnson$168
- AbbVie$145
- Sunovion Pharmaceuticals Inc.$126
- plus $669 from 20 others
What the payments were for
- Food & beverage$1,876100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $311 |
| Pfizer | 12 | $231 |
| Amgen | 14 | $227 |
| Johnson & Johnson | 10 | $168 |
| AbbVie | 10 | $145 |
| Sunovion Pharmaceuticals Inc. | 8 | $126 |
| Astellas Pharma US Inc | 7 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $87 |
| Lilly USA, LLC | 5 | $72 |
| AstraZeneca | 3 | $49 |
| Boehringer Ingelheim | 2 | $41 |
| Ultragenyx Pharmaceutical Inc. | 2 | $39 |
| Genentech USA, Inc. | 2 | $36 |
| GSK | 3 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Insulet Corporation | 1 | $23 |
| Boston Scientific | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Novartis | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Merck | 1 | $12 |
How this compares
$1,876 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 21 | $168 |
| Lisinopril | 19 | $126 |
| Tamsulosin Hcl | 14 | $118 |
| Donepezil Hcl | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bourbon
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
- Jeffrey HiltzMuncie$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.